Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Pulmonary Fibrosis to Respiratory Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Pulmonary Fibrosis to Respiratory Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Pulmonary Fibrosis Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 229
Abbreviations 229
Definitions 229
Research Methodology 230
Secondary Research 230
About GlobalData 231
Contact Us 231
Disclaimer 231
Source 232

List of Tables
Pulmonary Fibrosis Therapeutics, Global, Clinical Trials by Region, 2016* 6
Pulmonary Fibrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Pulmonary Fibrosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Pulmonary Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Pulmonary Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Pulmonary Fibrosis Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Pulmonary Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
Pulmonary Fibrosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
Proportion of Pulmonary Fibrosis to Respiratory Clinical Trials, G7 Countries (%), 2016* 14
Pulmonary Fibrosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Pulmonary Fibrosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Pulmonary Fibrosis to Respiratory Clinical Trials, E7 Countries (%), 2016* 17
Pulmonary Fibrosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Pulmonary Fibrosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Pulmonary Fibrosis Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Pulmonary Fibrosis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Pulmonary Fibrosis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Pulmonary Fibrosis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Pulmonary Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Pulmonary Fibrosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Pulmonary Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Pulmonary Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Pulmonary Fibrosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List of Figures
Pulmonary Fibrosis Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Pulmonary Fibrosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Pulmonary Fibrosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Pulmonary Fibrosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Pulmonary Fibrosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Pulmonary Fibrosis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Pulmonary Fibrosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
Pulmonary Fibrosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
Proportion of Pulmonary Fibrosis to Respiratory Clinical Trials, G7 Countries (%), 2016* 14
Pulmonary Fibrosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Pulmonary Fibrosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Pulmonary Fibrosis to Respiratory Clinical Trials, E7 Countries (%), 2016* 17
Pulmonary Fibrosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Pulmonary Fibrosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Pulmonary Fibrosis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Pulmonary Fibrosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Pulmonary Fibrosis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Pulmonary Fibrosis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Pulmonary Fibrosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Pulmonary Fibrosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Pulmonary Fibrosis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Pulmonary Fibrosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Pulmonary Fibrosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 230